L'etoposide per via Intravescicale Nella Chemioprofilassi Degli Uroteliomi Superficiali Della Vescica

1 Arnold A. M. : Podophyllotoxin derivative VP 16-213. Cancer Chemother. Pharmacol., 3; 71–80 (1979).

2 Issell B. F. , Crooke S. T. : Etoposide (VP 16-213). Cancer Treat. Rev., 6; 107–124 (1979).

3 Issell B. F. , Rudolph A. R. , Louie A. C. : Etoposide (VP 16-213): an overview. In: Etoposide (VP 16) current status and new developments. Issell B. F. , Muggia F. M. , Carter S. K. (eds.). Academic Press Inc., New York 1984.

4 Kurth K. H. , Denis L. , Schulman C. , Sylvester R. , De Paw M. , Dalesio O. : Adjuvant chemotherapy of superficial bladder carcinomas T_a/T₁: results of EORTC studies. In: Therapy and prophylaxis of superficial bladder carcinomas. Huland H. , Klosterhalfen H. (eds.). Georg Thieme Verlag, Stuttgart New York 1985.

5 Kurth K. H. , Schroder F. H. , Tunn U. , Ay R. , Pavone-Macaluso M. , Debruyne F. , De Paw M. , Dalesio O. , Ten Kate F. , Members of EORTC, Genitourinary Tract Cancer Cooperative Group: Adjuvant chemotherapy of superficial transitional cells bladder carcinoma: preliminary results of a EORTC randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone. J. Urol., 132; 258–262 (1984).

6 O'Dwyer P. J. , Leyland-Jones B. , Alonso M. T. , Morsoni S. , Wittes R. E. : Etoposide (VP 16-213): current status of an active anticancer drug. N. Engl. J. Med., 312; 692–700 (1985).

7 Phyllips N. C. , Lauper R. D. : Review of etoposide. Clin. Pharmacy, 2; 112–119 (1983).